A BREAST-OVARIAN CANCER SUSCEPTIBILITY GENE MAPS TO CHROMOSOME-17Q21

被引:0
作者
FEUNTEUN, J
NAROD, SA
LYNCH, HT
WATSON, P
CONWAY, T
LYNCH, J
PARBOOSINGH, J
OCONNELL, P
WHITE, R
LENOIR, GM
机构
[1] INT AGCY RES CANC,ISO COURS ALBERT THOMAS,F-69372 LYON 08,FRANCE
[2] INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,URA 1158,F-94805 VILLEJUIF,FRANCE
[3] MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA
[4] MCGILL UNIV,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA
[5] MCGILL UNIV,DEPT ONCOL,MONTREAL H3A 2T5,QUEBEC,CANADA
[6] CREIGHTON UNIV,SCH MED,DEPT PREVENT MED,OMAHA,NE 68178
[7] UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nineteen North American Caucasian families that contain a minimum of four confirmed cases of breast or ovarian cancer have been studied. Four polymorphisms (cLB17.1, D17S579, D17S588, and D17S74), which span a region of approximately 15 cM on chromosome 17q12, were typed. Our data confirm the location of a dominant gene conferring susceptibility to breast and ovarian cancer (maximum lod = 9.78) and suggest that the breast-ovarian cancer syndrome is genetically heterogeneous. Two recombinants in one large family suggest that the breast-ovarian cancer locus lies between D17S588 and D17S579.
引用
收藏
页码:736 / 742
页数:7
相关论文
共 14 条
[11]   POWER OF THE ADMIXTURE TEST TO DETECT GENETIC-HETEROGENEITY [J].
NAROD, SA .
GENETIC EPIDEMIOLOGY, 1991, 8 (04) :209-216
[12]  
OTT J, 1985, ANAL HUMAN GENETIC L
[13]   LINKAGE DETECTION TESTS UNDER HETEROGENEITY [J].
RISCH, N .
GENETIC EPIDEMIOLOGY, 1989, 6 (04) :473-480
[14]  
YOUNG JL, 1981, NATL CANCER I MONOGR, V57, P1